De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide-Reference-Cited by-同舟云学术

De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide

Published:2017-08-31 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Entzminger Kevin C.,Hyun Jeong-min,Pantazes Robert J.,Patterson-Orazem Athena C.,Qerqez Ahlam N.,Frye Zach P.,Hughes Randall A.,Ellington Andrew D.,Lieberman Raquel L.,Maranas Costas D.,Maynard Jennifer A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-10737-9.pdf

Reference41 articles.

1. Ecker, D. M., Jones, S. D. & Levine, H. L. The therapeutic monoclonal antibody market. MAbs 7, 9–14 (2015).

2. Vanhee, P. et al. Computational design of peptide ligands. Trends Biotechnol 29, 231–239 (2011).

3. Fjell, C. D., Hiss, J. A., Hancock, R. E. & Schneider, G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11, 37–51 (2012).

4. Azoitei, M. L. et al. Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5. Proteins 82, 2770–2782 (2014).

5. Fleishman, S. J. et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332, 816–821 (2011).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo;Nuclear Medicine and Biology;2024-09

2. Structural Basis for Recognition of the FLAG-tag by Anti-FLAG M2;Journal of Molecular Biology;2024-08

3. Engineering transcriptional regulation for cell-based therapies;SLAS Technology;2024-04

4. A quantitative comparison of antibodies against epitope tags for immunofluorescence detection;FEBS Open Bio;2023-11-03

5. Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties;mAbs;2023-01-11